# US 6,730,287 B1 · Methods for identifying compounds that modulate vigilance states

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 6,730,287 B1
- Document ID: US6730287B1
- Status: Granted
- Kind: B1
- Application number: 09/718,828
- Filed: 2000-11-22
- Granted: 2004-05-04
- Earliest claimed: 2000-04-03
- Assignees: Neurosciences Research Foundation, Inc.
- Inventors: Giulio Tononi; Chiara Cirelli; Paul J. Shaw; Ralph J. Greenspan
- Web page: https://patentgrep.com/patent/US6730287B1

## CPC

- A61K 49/0004: {Screening or testing of compounds for diagnosis of disorders, assessment of conditions, e.g. renal clearance, gastric emptying, testing for diabetes, allergy, rheuma, pancreas functions}
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)

## Abstract

The invention provides a method of identifying a compound that alters vigilance. The method consists of contacting an invertebrate with a candidate compound, evaluating a vigilance property in the contacted invertebrate, and determining if the candidate compound alters the vigilance property in the contacted invertebrate. A candidate compound that alters the vigilance property in the contacted invertebrate is identified as a compound that alters vigilance. The invention also provides a method of identifying a vigilance enhancing compound that modulates homeostatic regulation or a vigilance diminishing compound that modulates homeostatic regulation. The method consists of contacting an invertebrate with a compound that increases or decreases vigilance, and determining the effect of the compound on a homeostatic regulatory property of vigilance. A compound that alters the homeostatic regulatory property is characterized as being a vigilance enhancing compound or a vigilance diminishing compound that modulates homeostatic regulation.

## Claims

### Claim 1

A method of identifying a compound that alters vigilance, comprising:
(a) contacting an invertebrate with a candidate compound;
(b) evaluating a behavioral vigilance property in said contacted invertebrate wherein said behavioral vigilance property is selected from the group consisting of activity during the normal sleep period, activity following sleep deprivation, arousal threshold, and latency to sleep; and
(c) determining if said candidate compound alters said property in said contacted invertebrate,
wherein a candidate compound that alters said property in said contacted invertebrate is identified as a compound that alters vigilance.

### Claim 2 (depends on 1)

The method of claim 1, wherein said vigilance property is activity during the normal sleep period.

### Claim 3 (depends on 1)

The method of claim 1, wherein said vigilance property is activity following sleep deprivation.

### Claim 4 (depends on 1)

The method of claim 1, wherein said vigilance property is latency to sleep.

### Claim 5 (depends on 4)

The method of claim 4, wherein said latency to sleep is evaluated following sleep deprivation.

### Claim 6 (depends on 2)

The method of claim 2, wherein said activity is evaluated using an ultrasound or an infrared monitoring system.

### Claim 7 (depends on 1)

The method of claim 1, wherein said vigilance property is arousal threshold.

### Claim 8 (depends on 1)

The method of claim 1, wherein said vigilance property is expression of one or more vigilance-modulated genes selected from the group consisting of Fas, Cytochrome oxidase C subunit I, Cyp4e2, BiP, and Dat.

### Claim 9 (depends on 1)

The method of claim 1, wherein said invertebrate is an insect.

### Claim 10 (depends on 9)

The method of claim 9, wherein said insect is a Drosophila species.

### Claim 11 (depends on 10)

The method of claim 10, wherein said Drosophila species is Drosophila melanogaster.

### Claim 12 (depends on 1)

The method of claim 1, wherein said contacting comprises feeding said candidate compound to said invertebrate.

### Claim 13 (depends on 1)

The method of claim 1, wherein said compound that alters vigilance increases vigilance.

### Claim 14 (depends on 1)

The method of claim 1, wherein said compound that alters vigilance decreases vigilance.

### Claim 15 (depends on 1)

The method of claim 1, further comprising evaluating memory or learning.

### Claim 16

A method of identifying a compound that alters vigilance, comprising:
(a) contacting an invertebrate with a candidate compound;
(b) evaluating a molecular vigilance property in said contacted invertebrate and
(c) determining if said candidate compound alters said property in said contacted invertebrate,
wherein a candidate compound that alters said property in said contacted invertebrate is identified as a compound that alters vigilance.

### Claim 17 (depends on 16)

The method of claim 16, wherein said invertebrate is an insect.

### Claim 18 (depends on 17)

The method of claim 17, wherein said insect is a Drosophila species.

### Claim 19 (depends on 18)

The method of claim 18, wherein said Drosophila species is Drosophila melanogaster.

### Claim 20 (depends on 16)

The method of claim 16, wherein said contacting comprises feeding said candidate compound to said invertebrate.

### Claim 21 (depends on 16)

The method of claim 16 wherein said compound that alters vigilance increases vigilance.

### Claim 22 (depends on 16)

The method of claim 16, wherein said compound that alters vigilance decreases vigilance.

### Claim 23 (depends on 16)

The method of claim 16, further comprising evaluating memory or learning.
